Open AccessPB2056: MYELOFIBROSIS IN PATIENTS OLDER THAN 70 YEARS: IS TREATMENT WITH RUXOLITINIB WORTH IT?
Author(s) -
Montero M. I.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000851056.70678.c8
Subject(s) - myelofibrosis , ruxolitinib , medicine , myeloproliferative neoplasm , anemia , incidence (geometry) , gastroenterology , overall survival , log rank test , survival analysis , surgery , bone marrow , physics , optics